Structures by: Samba M.
Total: 5
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C19H18N2O2
IUCrData (2018) 3, 2 x180326
a=8.9229(5)Å b=18.8922(10)Å c=9.7147(5)Å
α=90° β=104.8790(10)° γ=90°
(4<i>Z</i>)-4-[1-(2-Aminoanilino)ethylidene]-3-methyl-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-5-one
C18H18N4O
IUCrData (2017) 2, 2 x170256
a=8.6575(2)Å b=7.17490(10)Å c=25.3062(5)Å
α=90° β=93.7820(10)° γ=90°
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C19H18N2O2
IUCrData (2016) 1, 9 x161448
a=8.2829(2)Å b=13.8636(4)Å c=15.1292(4)Å
α=72.3280(10)° β=74.9220(10)° γ=87.2520(10)°
Tetrakis(N,N-dimethyl,N'-phenylthiourea-S)cadmium(II)diperchlorate
C36H48CdCl2N8O8S4
Analytical Sciences: X-ray Structure Analysis Online (2004) 20, x3-x4
a=11.082(3)Å b=35.856(8)Å c=12.135(3)Å
α=90.00° β=106.04(2)° γ=90.00°
3-(4,4-Dimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-ylidene)-6-methyl-3,4-dihydro-2<i>H</i>-pyran-2,4-dione
C17H18N2O3
Acta Crystallographica Section E (2019) 75, 2 228-232
a=5.53730(10)Å b=24.0197(4)Å c=11.7815(3)Å
α=90° β=103.488(2)° γ=90°